Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.55% |
| 2 | Consumer Discretionary | 0.95% |
| 3 | Financials | 0.77% |
| 4 | Healthcare | 0.67% |
| 5 | Industrials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
CALL
Lemonade
LMND
$4.21B
| $36.8M | 0.01% |
1,170,100
-296,600
| -20% | -$10.2M |
|
1227
Biogen
BIIB
$32.6B
| $36.7M | 0.01% |
268,372
-216,676
| -45% | -$31M |
|
1228
ServiceNow
NOW
$131B
| $36.7M | 0.01% |
230,590
-289,785
| -56% | -$55.9M |
|
1229
PUT
Listed Funds Trust Roundhill Magnificent Seven ETF
MAGS
$4.18B
| $36.7M | 0.01% |
800,100
+760,500
| +1,920% | +$39.7M |
|
1230
CALL
Petrobras Class A
PBR.A
$103B
| $36.7M | 0.01% |
2,812,500
+2,620,900
| +1,368% | +$32.9M |
|
1231
CALL
Coherent
COHR
$56.4B
| $36.7M | 0.01% |
564,600
-473,600
| -46% | -$39.2M |
|
1232
CALL
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| $36.6M | 0.01% |
808,900
+433,300
| +115% | +$19.5M |
|
1233
CALL
Canadian Natural Resources
CNQ
$102B
| $36.6M | 0.01% |
1,187,500
+153,400
| +15% | +$4.65M |
|
|
ECHO
1234
CALL
EchoStar
ECHO
$25.1B
| $36.5M | 0.01% |
1,428,500
-102,100
| -7% | -$2.78M |
|
|
1235
PUT
Canadian Natural Resources
CNQ
$102B
| $36.5M | 0.01% |
1,185,800
+131,900
| +13% | +$4M |
|
|
BPMC
1236
DELISTED
Blueprint Medicines
BPMC
| $36.5M | 0.01% |
412,540
+276,329
| +203% | +$27M |
|
1237
PUT
Aflac
AFL
$58.2B
| $36.4M | 0.01% |
327,800
+30,300
| +10% | +$3.21M |
|
1238
Sun Communities
SUI
$15.3B
| $36.4M | 0.01% |
283,107
-16,800
| -6% | -$2.15M |
|
1239
CALL
D-Wave Quantum Inc
QBTS
$7.21B
| $36.3M | 0.01% |
4,771,400
+2,641,100
| +124% | +$17.7M |
|
1240
PUT
Bloom Energy
BE
$64B
| $36.2M | 0.01% |
1,843,000
-191,600
| -9% | -$4.57M |
|
|
WBA
1241
PUT
DELISTED
Walgreens Boots Alliance
WBA
| $36.1M | 0.01% |
3,232,300
-1,159,200
| -26% | -$12.6M |
|
1242
ConocoPhillips
COP
$158B
| $36.1M | 0.01% |
343,770
-562,236
| -62% | -$56.1M |
|
1243
Advance Auto Parts
AAP
$2.63B
| $36.1M | 0.01% |
920,053
+776,892
| +543% | +$33.3M |
|
1244
CALL
Natera
NTRA
$48.5B
| $36M | 0.01% |
254,800
-40,300
| -14% | -$6.48M |
|
1245
CALL
Enbridge
ENB
$109B
| $36M | 0.01% |
812,000
+430,000
| +113% | +$18.7M |
|
1246
CALL
Viking Therapeutics
VKTX
$3.99B
| $36M | 0.01% |
1,489,400
-681,100
| -31% | -$21.5M |
|
1247
PUT
Toll Brothers
TOL
$13.9B
| $36M | 0.01% |
340,500
-370,100
| -52% | -$44.4M |
|
|
PPL
1248
CALL
PPL Corp
PPL
$26.3B
| $35.9M | 0.01% |
995,200
+361,400
| +57% | +$12.3M |
|
1249
PUT
American Electric Power
AEP
$66.8B
| $35.7M | 0.01% |
326,800
+36,300
| +12% | +$3.68M |
|
1250
CALL
Sempra
SRE
$54.9B
| $35.6M | 0.01% |
498,700
+421,300
| +544% | +$32.8M |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass withdrew a net $24.4B in Q1 2025, closing 1,482 positions and reducing 4,842 holdings. Its most notable exit was Inari Medical, Inc. Common Stock, an estimated $24M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 2% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jeff Yass opened a new position in Brookfield Asset Management worth $86M.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.